Download the Whitepaper
The rate at which people are dying of opioid overdoses in America is accelerating. Medication-assisted treatment (MAT) alongside harm-reduction measures such as needle exchanges and supervised injection facilities have proven successful in other countries, but have failed to gain support in the U.S.
We set up a Creative Focus test to determine where popular support currently stands on MAT and needle exchanges, and which messages impact support levels.
At Civis, we take a science-first approach to solving business problems using person-level data. With a blend of proprietary technology and statistical advisory services, we help public and private sector organizations find, understand, and connect with the people they care about, so they can stop guessing and start using statistical proof to guide decisions. We know others use “data science” and “analytics” as buzzwords, but at Civis we don’t stand for fluff, and we will always deliver scalable products and technologies — not PowerPoints — to drive your business forward.